Drug abuse

Back pain
#Chronic pain #Drug abuse #FDA #Opioids #Painkillers #Protega

FDA approves abuse-deterrent immediate-release 10mg opioid

The US Food and Drug Administration (FDA) has approved Roxybond (oxycodone hydrochloride) 10mg for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. The approval makes Roxybond the first FDA-approved abuse-deterrent immediate release (IR) 10mg oxycodone formulation… Read More

#News #Regulatory

#Addiction #Antibodies #Cessation Therapeutics #Drug abuse #Monoclonal antibodies #Opioids #Overdose

Can an antibody therapy prevent fentanyl overdoses?

DDW Editor Reece Armstrong speaks to Tracy M Woody, President and Chief Executive Officer of Cessation Therapeutics, about the company’s goal to develop an antibody therapy to prevent fentanyl overdoses. Cessation Therapeutics is a pharmaceutical company that is developing antibody therapies to prevent and reverse overdosing… Read More

#Exclusive Content